Lilly Launches LillyPod, World's Leading AI Factory for Drug Discovery, Powered by Over 1,000 NVIDIA Blackwell Ultra GPUs

LillyPod, equipped with over 1,000 NVIDIA Blackwell Ultra GPUs, is now operational, providing powerful computing capabilities for scientific research and accelerating the future development of medicine.

Saving and improving lives, humanity’s greatest endeavor, is now powerfully supported by supercomputing.

Eli Lilly recently launched a world-leading AI factory, fully owned and operated by the pharmaceutical company, designed to help its teams achieve major medical breakthroughs faster, more accurately, and at an unprecedented scale. The facility is named LillyPod.

Powered by a DGX SuperPOD equipped with 1,016 NVIDIA Blackwell Ultra GPUs, the Eli Lilly AI Factory delivers over 9,000 petaFLOPS of AI performance. The facility was assembled in just four months.

LillyPod held its ribbon-cutting ceremony and officially opened in Indianapolis.

Diogo Rau, Executive Vice President and Chief Information and Digital Officer at Eli Lilly and Company, stated, “The launch of this supercomputer holds profound significance for us, representing 150 years of sustained investment and accumulation. LillyPod powerfully embodies our mission and founding commitment: to create better lives for people around the world. At this pivotal moment, we are positioned to advance biology in unprecedented ways.”

The above is the abstract. Click “Read Full Article” or scan the QR code below to read the full content: